Litigation Details for Nippon Shinyaku.,Ltd. v. Sarepta Therapeutics, Inc. (D. Del. 2021)
✉ Email this page to a colleague
Nippon Shinyaku.,Ltd. v. Sarepta Therapeutics, Inc. (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-07-13 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,227,590; 10,266,827; 9,994,851 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Nippon Shinyaku.,Ltd. v. Sarepta Therapeutics, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Nippon Shinyaku.,Ltd. v. Sarepta Therapeutics, Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-07-03 | 248 | Opinion - Memorandum Opinion | infringement of U.S. Patent Nos. 9,994,851 ("the ' 851 patent"), 10,227,590 ("the '…x27; 851 patent, claims 1 and 2 of the '590 patent, and claim 1 of the ' 827 patent. The parties…See ' 851 patent at claim 1; see also ' 590 patent at claim 1; '827 patent at claim 1. …See '851 patent at claim 1; see also ' 590 patent at claim 1; ' 827 patent at claim 1.…x27; 851 patent, claims 1 and 2 of the ' 590 patent, and claim 1 of the ' 827 patent. The parties | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
